Physician profile
Thomas Blomquist
NPI 1215996178
$4,334.49
in general payments reported to CMS, 2019-2025
10 companies · $76.65 in 2025
The $76.65 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,609 · 2020: $666 · 2022: $696 · 2023: $231 · 2024: $56.13 · 2025: $76.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,885.04 | 2019-2022 | |
| Davol INC. | $996.90 | 2019-2025 | Phasix Mesh |
| Idorsia Pharmaceuticals US INC | $103.25 | 2023 | Quviviq |
| Medtronic, INC. | $92.92 | 2023 | Signia |
| Kci USA, INC. | $90.04 | 2020-2023 | Prevena, V.A.C. Veraflo |
| Dilon Technologies, INC. | $56.13 | 2024 | Hemoblast Bellows |
| Smith+Nephew, INC. | $48.45 | 2025 | Grafix Pl |
| Avanos Medical | $34.81 | 2020 | |
| Aroa Biosurgery Incorporated | $14.33 | 2023 | |
| Acell, INC. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Blomquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.